| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7K | — | — |
| R&D Expense | $46K | — | -55.3% |
| SG&A Expense | $1.6M | — | +553.2% |
| Operating Income | -$2.3M | — | -126.6% |
| Pre-tax Income | -$2.3M | — | -78.7% |
| Net Income | -$2.3M | — | -80.5% |
| EPS (Basic) | -$0.02 | — | +81.8% |
| EPS (Diluted) | -$0.02 | — | +81.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $20K | +566.7% | -98.5% |
| Accounts Receivable | $5K | +0.0% | +25.0% |
| Inventory | $63K | +0.0% | -87.1% |
| Current Assets | $377K | -8.3% | -82.7% |
| Total Assets | $17.1M | -1.8% | -14.8% |
| Current Liabilities | $1.7M | +45.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$464K | — | +32.0% |
| Investing Cash Flow | -$1K | — | -200.0% |
| Financing Cash Flow | $482K | — | — |
| -83.1% |
| Total Liabilities | $2.4M | +28.4% | -82.1% |
| Stockholders' Equity | $11.5M | -9.1% | +198.3% |